论文信息 - Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up - 字舞流文

Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up

S. Culine | M. Climent | T. Choueiri | D. Bajorin | C. Sternberg | J. Bellmunt | D. Petrylak | D. Quinn | N. Vogelzang | R. de Wit | D. Vaughn | L. Fong | A. Necchi | W. Gerritsen | Y. Fradet | H. Gurney | R. Perini | T. Frenkl | K. Nam | D. Petrylak | J. Lee | J. Lee | R. D. Wit